Skip to main content
Shop Plans Learn more about our coverage options including health, Medicare, dental and vision options for you, your family or your employees. Get Started Individual & Family Medicare Employer Vision Dental International Travel Find Care FAQ Blog Members Stay on top of your health care with helpful member resources. Members Home Medicare Health Dental Vision Find Care Member Knowledge Center Member Forms Medicare Forms Library Make a Payment Federal Employees Student Blue Healthy Blue Providers Access tools, policies and the latest information to help you care for our members. Providers Home Network Participation Networks & Programs Claims, Appeals & Inquiries Prior Authorization Services & CPT codes Prescription Drug Search Policies, Guidelines & Codes Provider News Provider FAQ Contact Us Employers Learn about our coverage options for small and large employers, and access tools and resources for your group. Employers Home Shop Employer Plans Employer Portal Support Member Forms & Resources Find Care Blog Agents Access the tools you need: rate quotes, applications, forms, the latest industry news, marketing materials and more. Agents Home Agent Services Check Eligibility Find Care Member Forms & Resources Medicare Forms Library
Contact Us
Log In
I am ... Please select A member A provider An employer An agent
Log in to Agent Services
Log in to Employer Services Register for Employer Services I'm registered but need portal access
Username Forgot username? Continue to Log In Register for Blue Connect Need help? Learn how to log in.
Log in to Blue e Register for Blue e Log in to Dental Blue
Back
Medical Policy Update for June 30, 2022 June 30, 2022
Medical GuidelinesReason for Update
Bariatric SurgeryReferences added. Medical Director review. Amended statement 5 on page 2 by adding the words “one anastomosis gastric bypass (OAGB)” and removing the words “mini gastric bypass”. Code 43659 added. The following statements were added: “One anastomosis gastric bypass (OAGB) is a “combined procedure”, and it has both a “restrictive” and a “malabsorptive” component”, “The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) issued a position statement on the role of one anastomosis gastric bypass (OAGB) in the field of bariatric/metabolic surgery in 2018. In order to avoid confusion between the Billroth II Gastrojejunostomy and the Roux en Y procedure, OAGB has been recommended as the preferred terminology”, and “The unlisted stomach code, CPT 43659, is most appropriate for the OAGB at this time”. On page 7 under When Bariatric Surgery is covered, added “One anastomosis gastric bypass (OAGB) using the Billroth II gastrojejunostomy with gastric partitioning”. On page 8 under When Bariatric Surgery is not covered, removed “Gastric bypass using a Billroth II type of anastomosis, popularized as the mini gastric bypass”.
Capsule Endoscopy, WirelessPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Updated Regulatory Status under the Description section. Added investigational statement regarding magnetic capsule endoscopy to the When Not Covered section as follows: “Magnetic capsule endoscopy is considered investigational for the evaluation of patients with unexplained upper abdominal complaints and all other indications.” Policy guidelines updated. No change to policy intent. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Electrogastrography, CutaneousPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Enteral NutritionPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Esophageal Pathology Testing AHS – M2171Off-cycle minor revision: added the following statement to the Description section, “For guidance concerning Tumor Mutational Burden Testing (TMB) and/or Microsatellite instability (MSI) analysis please refer to the AHS-M2178-Microsatellite Instability and Tumor Mutational Burden Testing policy.”; added AHS M2178 to the Related Policies section.
Esophageal pH MonitoringPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Minor update to Description section. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Gastric Electrical StimulationPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
General Genetic Testing, Germline Disorders AHS – M2145Reviewed by Avalon 1st Quarter 2022 CAB. Policy guidelines updated; added Table of Terminology. The following codes were added to Billing/Coding section: 0269U, 0270U, 0271U, 0272U, 0273U, 0274U, 0276U, 0277U, 0318U. Medical Director review 4/2022.
Growth Factors in Wound HealingPolicy Guidelines updated.
Investigational (Experimental) ServicesCOVID-19 related changes extended “effective from March 6, 2020, through September 30, 2022. We will reevaluate if an additional extension is needed as we approach September 30.” Medical Director review.
Laboratory Procedures Medical Policy AHS - R2162The following PLA code was added to the Billing/Coding section: 0331U.
Molecular Markers in Fine Needle Aspirates of the Thyroid AHS - M2108Reviewed by Avalon Q1 2022 CAB. Medical Director review 4/2022.Added PLA code 0287U to Billing/Coding section effective 7/1/22. Deleted Notes 1&2 for removal of 50 gene limit for cancer screening. Added new note for 5 or more gene tests run on the same platform. Updated policy guidelines and added references.
Non-Contact Ultrasound Treatment for WoundsRoutine policy review.
Pancreas TransplantPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent. Description section updated. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Pathogen Panel Testing AHS – G2149The following PLA codes were added to the Billing/Coding section: 0323U, 0330U.
Peroral Endoscopic Myotomy for Treatment of Esophageal AchalasiaPolicy title updated. Policy formatting updated to align with the new utilization management tool. No changes to policy statement or intent.
Prenatal Screening for Fetal Aneuploidy AHS – G2055Added 0327U to billing/coding section effective 7/1/2022.
Prescription Medication and Illicit Drug Testing in the Outpatient Setting AHS – T2015Added code 0328U to billing/coding section. Effective 7/1/2022.
Small Bowel, Small Bowel with Liver, or Multivisceral TransplantPolicy titled updated. Policy formatting updated to align with new utilization management tool. No changes to policy statement or intent. Specialty Matched Consultant Advisory Panel 5/2022. Medical Director review 5/2022.
Testosterone Testing AHS – G2013Added the following, “For Policy Titled: Hormonal Testing in Adult Males” to implementation section for clarity.
Therapeutic Radiopharmaceuticals in OncologyWhen covered section updated to add “Radiopharmaceuticals are eligible for coverage for indications supported by an NCCN (National Comprehensive Cancer Network) 1 or 2A recommendation when all requirements, e.g. performance status, disease severity, previous failures, and mono- versus combination therapy, as well as the requested dose and treatment duration are met.” Policy Guidelines updated. References updated. Medical Director review 6/2022.
Whole Genome and Whole Exome Sequencing AHS – M2032The following PLA code was added to the Billing/Coding section: 0329U.